Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · November 06, 2024

Effect of Treatment With Ritlecitinib on Patient-Reported Hair Loss Among Patients With Alopecia Areata

American Journal of Clinical Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

American Journal of Clinical Dermatology
Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
Am J Clin Dermatol 2024 Oct 23;[EPub Ahead of Print], R Sinclair, N Mesinkovska, D Mitra, D Wajsbrot, EH Law, R Wolk, B King

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading